Natural Molecule Could Improve Parkinson's
A natural molecule shows benefit in preliminary clinical trial for Parkinson’s Disease
According to many, the lack of dopamine in the brain is thought to be the cause of Parkinson’s disease. Current treatments for Parkinson’s include replacing dopamine within the brain and medications that are designed to slow the progression of the disease. In this study, researchers found that the natural molecule, n-acetylcysteine (NAC), with it’s strong antioxidant effects, could potentially benefit Parkinson’s disease management for patients. “This study reveals a potentially new avenue for managing Parkinson’s patients and shows that n-acetylcysteine may have a unique physiological effect that alters the disease process and enables dopamine neurons to recover some function,” said senior author on the paper Daniel Monti, MD, MBA, director of the Myrna Brind Center of Integrative Medicine and the Brind-Marcus Center of Integrative Medicine at Thomas Jefferson University. To read more, click here.
Spine World Summit
Jan. 26, 2018 - Jan. 27, 2018; Hong Kong
6th Ottawa Neurosurgery Review Course
Feb. 3, 2018 - Feb. 10, 2018; Ottawa, ON Canada
Winter Clinics for Cranial and Spinal Surgery
Feb. 25, 2018 - Mar. 1, 2018; Snowmass Village, Colo.
69th Southern Neurosurgical Society Annual Meeting
Feb. 28, 2018 - Mar. 3, 2018; San Juan, PR
Second International Brain Mapping Course
April 26-27, 2018; New Orleans